Follow
Soumya Badrinath
Soumya Badrinath
Post Doctoral Fellow, Dana Farber Cancer Institute
Verified email at DFCI.HARVARD.EDU
Title
Cited by
Cited by
Year
Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell–driven tumor immunity
L Ferrari de Andrade, RE Tay, D Pan, AM Luoma, Y Ito, S Badrinath, ...
Science 359 (6383), 1537-1542, 2018
3742018
A facile approach to enhance antigen response for personalized cancer vaccination
AW Li, MC Sobral, S Badrinath, Y Choi, A Graveline, AG Stafford, ...
Nature materials 17 (6), 528-534, 2018
3292018
Neuropathology in mouse models of mucopolysaccharidosis type I, IIIA and IIIB
FL Wilkinson, RJ Holley, KJ Langford-Smith, S Badrinath, A Liao, ...
PloS one 7 (4), e35787, 2012
1912012
A vaccine targeting resistant tumours by dual T cell plus NK cell attack
S Badrinath, MO Dellacherie, A Li, S Zheng, X Zhang, M Sobral, ...
Nature 606 (7916), 992-998, 2022
812022
Position 156 influences the peptide repertoire and tapasin dependency of human leukocyte antigen B* 44 allotypes
S Badrinath, P Saunders, T Huyton, S Aufderbeck, O Hiller, R Blasczyk, ...
Haematologica 97 (1), 98, 2012
362012
Mismatches outside exons 2 and 3 do not alter the peptide motif of the allele group B* 44: 02P
C Bade-Doeding, P Cano, T Huyton, S Badrinath, B Eiz-Vesper, O Hiller, ...
Human Immunology 72 (11), 1039-1044, 2011
312011
Immunosuppressive Myeloid Cells Induce Nitric Oxide–Dependent DNA Damage and p53 Pathway Activation in CD8+ T Cells
ANR Cartwright, S Suo, S Badrinath, S Kumar, J Melms, A Luoma, ...
Cancer immunology research 9 (4), 470-485, 2021
192021
A Micropolymorphism Altering the Residue Triad 97/114/156 Determines the Relative Levels of Tapasin Independence and Distinct Peptide Profiles for HLA-A 24 Allotypes
S Badrinath, H Kunze-Schumacher, R Blasczyk, T Huyton, ...
Journal of Immunology Research 2014, 2014
162014
Position 45 influences the peptide binding motif of HLA-B* 44: 08
S Badrinath, T Huyton, H Schumacher, R Blasczyk, C Bade-Doeding
Immunogenetics 64, 245-249, 2012
122012
Differential impact of HLA-B∗ 44 allelic mismaches at position 156 on peptide binding specificities and T-cell diversity
S Badrinath, T Huyton, H Kunze-Schumacher, HA Elsner, R Blasczyk, ...
Journal of Stem Cell Research & Therapy 4 (4), 2014
52014
Non-expression of HLA-C* 07: 55N is caused by a premature stop codon in exon 3.
S Badrinath, R Blasczyk, C Bade-Doeding
Tissue antigens 79 (2), 2012
32012
HLA Class I Polymorphism and Tapasin Dependency
S Badrinath, T Huyton, R Blasczyk, C Bade-Doeding
HLA and Associated Important Diseases, 2014
12014
EVASION OF LOADING COMPLEX AND PRESENTATION OF NON-CANONICAL PEPTIDES BY HLA-E IMPACTS NKG2-MEDIATED CELLULAR FUNCTION
T Kraemer, H Schumacher, T Huyton, S Badrinath, S Moneer, R Blasczyk, ...
Tissue Antigens 81 (5), 264-265, 2013
12013
Composición de vacuna que comprende el dominio alfa 3 de mica/b (div. 2018-350)
S Badrinath, K Wucherpfennig
2023
Vaccination with mica/b alpha 3 domain for the treatment of cancer
KW Wucherpfennig, S Badrinath
US Patent App. 17/180,183, 2021
2021
Vaccination with MICA/B alpha 3 domain for the treatment of cancer
KW Wucherpfennig, S Badrinath
US Patent 10,993,971, 2021
2021
Vaccination with mica/b alpha 3 domain for the treatment of cancer
S Badrinath, K Wucherpfennig
2019
Vacunación con el dominio alfa 3 de mica/b para el tratamiento del cáncer
K Wucherpfennig, S Badrinath
2018
Development of Epitope-Focused Tumor Vaccine to Prevent Escape from Immune Surveillance by the NKG2D Pathway
S Badrinath, Dana-Farber Cancer Institute Boston United States
2017
Vaccination with mica/b alpha 3 domain for the treatment of cancer
K Wucherpfennig, S Badrinath
2017
The system can't perform the operation now. Try again later.
Articles 1–20